Development of Celiac Disease Therapeutics: Report of the Third Gastroenterology Regulatory Endpoints and Advancement of Therapeutics Workshop

被引:21
|
作者
Leffler, Daniel [1 ]
Kupfer, Sonia S. [2 ]
Lebwohl, Benjamin [3 ]
Bugin, Kevin [4 ]
Griebel, Donna [4 ]
Lathrop, Julia Tait [4 ]
Lee, Jessica J. [4 ]
Mulberg, Andrew E. [4 ]
Papadopoulos, Elektra [4 ]
Tomaino, Juli [4 ]
Crowe, Sheila E. [5 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[2] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[3] Columbia Univ, Dept Med, New York, NY USA
[4] US FDA, Silver Spring, MD USA
[5] Univ Calif San Diego, Dept Med, 9500 Gilman Dr,BRF 2,Off 4A30, La Jolla, CA 92093 USA
关键词
GLUTEN-FREE DIET; PREDICTORS; ANTIBODIES; DIAGNOSIS; MORTALITY; SYMPTOMS; ADULTS;
D O I
10.1053/j.gastro.2016.07.025
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:407 / 411
页数:5
相关论文
共 50 条
  • [31] Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics
    Spengler, Jessica R.
    Lo, Michael K.
    Welch, Stephen R.
    Spiropoulou, Christina F.
    CLINICAL MICROBIOLOGY REVIEWS, 2025, 38 (01)
  • [32] Huntington Disease: Linking Pathogenesis to the Development of Experimental Therapeutics
    Tiago A. Mestre
    Cristina Sampaio
    Current Neurology and Neuroscience Reports, 2017, 17
  • [33] Challenges and opportunities in the development of therapeutics for chronic kidney disease
    Shayman, James A.
    TRANSLATIONAL RESEARCH, 2015, 165 (04) : 482 - 487
  • [34] Advancement in the development of therapeutics against Zika virus infection (vol 12, 946957, 2022)
    Li, Kangchen
    Ji, Qianting
    Jiang, Shibo
    Zhang, Naru
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [35] Leveraging preclinical models for the development of Alzheimer disease therapeutics
    Scearce-Levie, Kimberly
    Sanchez, Pascal E.
    Lewcock, Joseph W.
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (07) : 447 - 462
  • [37] Integrated Applied Clinical Pharmacology in the Advancement of Rare and Ultra-Rare Disease Therapeutics
    Ryder, Steven
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (06) : 1485 - 1495
  • [38] Interfering with disease: a progress report on siRNA-based therapeutics
    Antonin de Fougerolles
    Hans-Peter Vornlocher
    John Maraganore
    Judy Lieberman
    Nature Reviews Drug Discovery, 2007, 6 : 443 - 453
  • [39] Interfering with disease: a progress report on siRNA-based therapeutics
    de Fougerolles, Antonin
    Vornlocher, Hans-Peter
    Maraganore, John
    Lieberman, Judy
    NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (06) : 443 - 453
  • [40] Polymeric carriers: Preclinical safety and the regulatory implications for design and development of polymer therapeutics
    Gaspar, Rogerio
    Duncan, Ruth
    ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (13) : 1220 - 1231